Cyclopentylate
Cyclopentylate Brand names, Cyclopentylate Analogs
Cyclopentylate Brand Names Mixture
- No information avaliable
Cyclopentylate Chemical_Formula
C17H25NO3
Cyclopentylate RX_link
No information avaliable
Cyclopentylate fda sheet
Cyclopentylate msds (material safety sheet)
Cyclopentylate Synthesis Reference
No information avaliable
Cyclopentylate Molecular Weight
291.385 g/mol
Cyclopentylate Melting Point
139 oC (hydrochloride salt)
Cyclopentylate H2O Solubility
No information avaliable
Cyclopentylate State
Solid
Cyclopentylate LogP
3.124
Cyclopentylate Dosage Forms
Ophthalmic solution (eye drops)
Cyclopentylate Indication
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Cyclopentylate Pharmacology
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
Cyclopentylate Absorption
Absorbed following ophthalmic administration.
Cyclopentylate side effects and Toxicity
Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.
Cyclopentylate Patient Information
No information avaliable
Cyclopentylate Organisms Affected
Humans and other mammals
